Colliding Epidemics During an Opioid Crisis: Impact of the COVID-19 Pandemic on Determinants of HIV and HCV Transmission Among People Who Inject Drugs
阿片类药物危机期间的流行病冲突:COVID-19 大流行对注射吸毒者中 HIV 和 HCV 传播决定因素的影响
基本信息
- 批准号:10471832
- 负责人:
- 金额:$ 4.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAgeAntiviral TherapyAnxietyAreaBaltimoreBehavioralBiological FactorsCOVID-19 pandemicCOVID-19 pandemic effectsCOVID-19 vaccinationCitiesCommunitiesCoupledDataDisease OutbreaksEnvironmentEpidemicEpidemiologistEpidemiologyEquationEquipmentFeelingFrequenciesFutureGoalsHIVHIV InfectionsHIV/HCVHarm ReductionHealthHealth Services AccessibilityHealthcareHepatitis CHepatitis C IncidenceHepatitis C PrevalenceHepatitis C TransmissionHepatitis C ViremiaHepatitis C co-infectionHepatitis C virusIndividualInjecting drug userInjectionsInterruptionInterviewIntravenousLinkMeasuresMental DepressionMentorsMethodsNational Institute of Drug AbuseNeedle SharingNeedle-Exchange ProgramsNeedlesNeighborhoodsParticipantPatient Self-ReportPatternPersonal SatisfactionPersonsPharmaceutical PreparationsPhasePopulationPopulation DecreasesPrevalencePsychosocial FactorPublic HealthPublic Health SchoolsQualitative ResearchResearchResearch TrainingRiskRisk FactorsRunningSamplingSeriesServicesSocial DistanceSocial isolationStressSubgroupTimeTime Series AnalysisTime trendTraining ProgramsTransportationUnited StatesUnited States Public Health ServiceVaccinationViremiaantiretroviral therapybasecohortdoctoral studenteffective therapyexperiencefollow-uphealth care availabilityhigh riskimprovedinjection drug uselong term consequences of COVID-19opioid epidemicopioid injectionopioid overdoseopioid use disorderpandemic diseaseprevention servicepsychosocialresidenceresponsescale upservice uptakeservice utilizationsocial contactsociodemographicsstatisticssubstance usetesting servicestransmission processtreatment servicestrenduptake
项目摘要
PROJECT SUMMARY/ABSTRACT
The U.S. plans to End the HIV Epidemic (EHE) and eliminate hepatitis C virus (HCV) infection by 2030. While
progress has been made in many groups including people who inject drugs (PWID), recent outbreaks of HCV
and HIV infection have been documented among PWID in the U.S and HCV incidence is increasing nationally
due to the opioid crisis. The COVID-19 pandemic, including the public health response, has resulted in
disruptions in access to services and created an environment that enables substance use. Indeed, the COVID-
19 pandemic may further threaten the U.S.' plan to EHE and eliminate HCV by exacerbating the opioid crisis.
The objective of this study is to assess the short- and long-term impacts of the COVID-19 pandemic on
individual- and community-level determinants of HIV and HCV transmission among PWID in Baltimore, MD.
The specific aims are to: (1) identify individual-level predictors of high-risk injection practices among PWID
during the COVID-19 pandemic, (2) examine trends in harm reduction utilization and identify associated
barriers and facilitators among PWID during the COVID-19 pandemic, and (3) evaluate the impact of the
COVID-19 pandemic on the population-level prevalence of HIV and HCV viremia among PWID. These aims
will be achieved by leveraging data from one of the largest and longest running cohorts of community-based
PWID worldwide—the AIDS Linked to the IntraVenous Experience (ALIVE) study in Baltimore, MD. Aim 1 will
identify pre-pandemic sociodemographic, behavioral, psychosocial, and biological factors associated with high-
risk injection practices during the pandemic using modified Poisson regression with generalized estimating
equations. Aim 2 will use a mixed-methods sequential explanatory approach to examine changes in the
population-level uptake of needle/syringe exchange services and medication for opioid use disorder before and
during different phases of the pandemic (2015-2021). In-depth interviews will be conducted with 25-30 PWID to
explore new barriers and facilitators to service utilization. Aim 3 will use an interrupted time-series analytic
approach to estimate the effect of the pandemic on the prevalence of HIV viremia and HCV viremia (2015-
2023). This study will inform whether the pandemic poses a major threat to the local and national goals to EHE
and eliminate HCV infection. This study will also inform the implementation of surveillance and programmatic
strategies to mitigate HIV/HCV transmission during the ongoing pandemic and opioid crisis as well as during
future periods of unrest and instability. The proposed study, which covers a high priority area for NIDA, will
serve as the doctoral dissertation for Mr. Eshan Patel, a PhD student in the Department of Epidemiology at the
Johns Hopkins Bloomberg School of Public Health. A comprehensive training program including mentored
research training from experts in HIV, HCV, and substance use epidemiology, psychosocial statistics,
qualitative research, and causal inference will provide the applicant a tailored experience to achieve his goal of
becoming an academic epidemiologist that contributes to the elimination of HIV and HCV among PWID.
项目概要/摘要
美国计划到 2030 年结束艾滋病毒流行 (EHE) 并消除丙型肝炎病毒 (HCV) 感染。
许多群体都取得了进展,包括注射吸毒者 (PWID)、最近爆发的丙肝病毒 (HCV)
在美国,吸毒者中已有 HIV 感染记录,HCV 发病率在全国范围内呈上升趋势
由于阿片类药物危机,包括公共卫生应对措施,导致了
事实上,新冠疫情扰乱了服务的获取,并创造了一个有利于物质使用的环境。
19 日的大流行可能会加剧阿片类药物危机,从而进一步威胁美国的 EHE 和消除 HCV 计划。
本研究的目的是评估 COVID-19 大流行对人们的短期和长期影响
马里兰州巴尔的摩注射吸毒者中艾滋病毒和丙型肝炎病毒传播的个人和社区层面的决定因素。
具体目标是:(1)确定注射吸毒者中高风险注射行为的个体水平预测因素
在 COVID-19 大流行期间,(2) 检查减少危害利用的趋势并确定相关的
COVID-19 大流行期间注射吸毒者的障碍和促进因素,以及 (3) 评估吸毒者的影响
COVID-19 大流行对吸毒者中 HIV 和 HCV 病毒血症人群流行率的影响。
将通过利用最大且运行时间最长的社区群体之一的数据来实现
全球注射吸毒者——在马里兰州巴尔的摩开展的艾滋病与静脉注射体验相关 (ALIVE) 研究将进行。
确定大流行前与高风险相关的社会人口、行为、心理和生物因素
大流行期间使用修正泊松回归和广义估计进行风险注入实践
目标 2 将使用混合方法顺序解释方法来检查方程的变化。
在使用针头/注射器交换服务和阿片类药物使用障碍药物之前和之后,人群接受针头/注射器交换服务和药物的情况
在大流行的不同阶段(2015-2021),将对 25-30 名注射吸毒者进行深入访谈。
探索服务利用的新障碍和促进因素 目标 3 将使用中断时间序列分析。
估计大流行对 HIV 病毒血症和 HCV 病毒血症流行率影响的方法(2015-
2023)。这项研究将揭示该流行病是否对地方和国家的 EHE 目标构成重大威胁。
这项研究还将为监测和规划的实施提供信息。
在持续的大流行和阿片类药物危机期间以及在
拟议的研究涵盖了 NIDA 的高度优先领域。
作为该校流行病学系博士生 Eshan Patel 先生的博士论文
约翰霍普金斯大学彭博公共卫生学院 全面的培训计划,包括指导。
由艾滋病毒、丙型肝炎病毒和药物滥用流行病学、心理社会统计学专家提供的研究培训,
定性研究和因果推理将为申请人提供量身定制的体验,以实现他的目标
成为一名学术流行病学家,为消除吸毒者中的艾滋病毒和丙型肝炎做出贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eshan Uday Patel其他文献
Eshan Uday Patel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eshan Uday Patel', 18)}}的其他基金
Colliding Epidemics During an Opioid Crisis: Impact of the COVID-19 Pandemic on Determinants of HIV and HCV Transmission Among People Who Inject Drugs
阿片类药物危机期间的流行病冲突:COVID-19 大流行对注射吸毒者中 HIV 和 HCV 传播决定因素的影响
- 批准号:
10674038 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别:
Colliding Epidemics During an Opioid Crisis: Impact of the COVID-19 Pandemic on Determinants of HIV and HCV Transmission Among People Who Inject Drugs
阿片类药物危机期间的流行病冲突:COVID-19 大流行对注射吸毒者中 HIV 和 HCV 传播决定因素的影响
- 批准号:
10323698 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别:
相似国自然基金
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 4.68万 - 项目类别:
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
SARS-CoV-2 抗病毒核糖核苷类似物对线粒体 DNA 的影响
- 批准号:
10448062 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别:
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
SARS-CoV-2 抗病毒核糖核苷类似物对线粒体 DNA 的影响
- 批准号:
10557154 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别:
Colliding Epidemics During an Opioid Crisis: Impact of the COVID-19 Pandemic on Determinants of HIV and HCV Transmission Among People Who Inject Drugs
阿片类药物危机期间的流行病冲突:COVID-19 大流行对注射吸毒者中 HIV 和 HCV 传播决定因素的影响
- 批准号:
10674038 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别:
Colliding Epidemics During an Opioid Crisis: Impact of the COVID-19 Pandemic on Determinants of HIV and HCV Transmission Among People Who Inject Drugs
阿片类药物危机期间的流行病冲突:COVID-19 大流行对注射吸毒者中 HIV 和 HCV 传播决定因素的影响
- 批准号:
10323698 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别: